Relation of alleles of the sodium-potassium adenosine triphosphatase α2 gene with blood pressure and lead exposure

American Journal of Epidemiology

Volumn 153, Issue 6, 2001, Pages 537-545

  Glenn, Barbara S ^a   Stewart, Walter F ^b,c   Schwartz, Brian S ^b,c,d   Bressler, Joseph ^a,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c The Johns Hopkins University   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; Genetic predisposition to disease; Genetics; Lead; Na(+) K(+) exchanging ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DNA; LEAD; ORGANOLEAD COMPOUND; TETRAETHYLLEAD; TETRAMETHYLLEAD;

ADULT; AGED; ALLELE; ARTICLE; BLOOD PRESSURE; CAUCASIAN; CHEMICAL INDUSTRY; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HYPERTENSION; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; NEGRO; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UNITED STATES;

ADULT; AGED; ALLELES; CHEMICAL INDUSTRY; GENOTYPE; HUMANS; HYPERTENSION; LEAD; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; NA(+)-K(+)-EXCHANGING ATPASE; NEW JERSEY; OCCUPATIONAL EXPOSURE; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0035869615     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/153.6.537     Document Type: Article

References (57)

1. National High Blood Pressure Education Program Working Group report on primary prevention of hypertension
2. Familial aggregation and genetic epidemiology of blood pressure
3. Molecular genetics of the renin-angiotensin-aldosterone system in human hypertension
4. Review of the relation between blood lead and blood pressure
5. Effects of lead and a low-molecular-weight endogenous plasma inhibitor on the kinetics of sodium-potassium-activated adenosine triphosphatase and potassium-activated p-nitrophenylphosphatase
6. Inhibition of brain cation pump enzyme by in vitro lead ion: Effects of low level [Pb] and modulation by homogenate
7. +-ATPase by trace metals: Relation to renal and cardiovascular damage
8. Inhibitory characteristics of lead chloride in sodium- and potassium-dependent adenosine triphosphatase preparations derived from kidney, brain, and heart of several species
9. Experimental model of lead nephropathy. III. Continuous low-level lead administration
10. +-ATPase activity of erythrocyte membranes in urban populations not occupationally exposed to lead
11. Red cell membrane ATPases in workers exposed to inorganic lead
12. +-adenosine triphosphatase
13. +-ATPase properties and adenylate energy charge in normotensives and in essential hypertensives
14. + and cell membrane adenosine triphosphatase activity in essential hypertension in blacks
15. Abnormal sodium transport in leucocytes from patients with essential hypertension and the effect of treatment
16. Erythrocyte concentrations and transmembrane fluxes of sodium and potassium in essential hypertension: Role of intrinsic and environmental factors
17. +-ATPase and blood pressure
18. +-ATPase
19. The human Na,K-ATPase alpha 1 gene characterization of the 5′-flanking region and identification of a restriction fragment length polymorphism
20. MspI and PvuII polymorphisms in the Na,K-ATPase beta subunit gene ATP1B1
21. Characterization of the human Na,K-ATPase alpha 2 gene and identification of intragenic restriction fragment length polymorphisms
22. +ATPase alpha subunit (ATP1A2) gene
23. + ATPase, alpha subunit (ATP1A3) gene
24. MspI and HindIII restriction fragment length polymorphisms at the human Na,K-ATPase beta-subunit (ATP1B) gene locus
25. Red cell membrane sodium transport: Possible genetic role and use in identifying patients at risk of essential hypertension
26. Sodium metabolism of offspring of hypertensive parents
27. 3H] ouabain binding
28. Leucocyte membrane sodium transport in normotensive populations: Dissociation of abnormalities of sodium efflux from raised blood-pressure
29. Decrements in neurobehavioral performance associated with mixed exposure to organic and inorganic lead
30. Predictors of blood lead levels in organolead manufacturing workers
31. Different associations of blood lead, DMSA-chelatable lead, and tibial lead in blood pressure in 543 former organolead manufacturing workers
32. In vivo x-ray fluorescence of lead in bone: Review and current issues
33. X-ray fluorescence: Issues surrounding the application of a new tool for measuring burden of lead
34. In vivo x-ray fluorescence of lead in bone
35. 109Cd sources: Radiation dosimetry studies
36. Recommendations for routine blood pressure measurement by indirect cuff sphygmomanometry
37. DNA variation in the genes of the Na,K-adenosine triphosphatase and its relation with resting metabolic rate, respiratory quotient, and body fat
38. Linkage of the Na,K-ATPase alpha 2 and beta 1 genes with resting and exercise heart rate and blood pressure: Cross-sectional and longitudinal observations from the Quebec Family Study
39. +-adenosine triphosphatase alleles and essential hypertension
40. Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men: The Normative Aging Study
41. Blood pressure, systolic and diastolic, and cardiovascular risks
42. High blood pressure in blacks: Salt, slavery, survival, stress, and racism
43. Blood lead levels in the US population: Phase 1 of the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1991)
44. Molecular basis of human hypertension: Role of angiotensinogen
45. Association of the alpha-adducin locus with essential hypertension
46. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension
47. Alpha-adducin gene polymorphism and cardiovascular phenotypes in a general population
48. Alanine scanning mutagenesis of oxygen-containing amino acids in the transmembrane region of the Na,K-ATPase
49. Functional role of oxygen-containing residues in the fifth transmembrane segment of the Na,K-ATPase alpha subunit
50. 2+-ATPase affects cation binding from both sides of the membrane and destabilizes the occluded enzyme forms
51. Site-directed mutagenesis of the Na,K-ATPase: Consequences of substitutions of negatively-charged amino acids localized in the transmembrane domains
52. Response of the cardiovascular system to catecholamines in rats given small doses of lead
53. Studies on the role of sodium- and potassium-activated adenosine triphosphatase inhibition in the pathogenesis of human hypertension
54. Endogenous ouabain, sodium balance and blood pressure: A review and a hypothesis